1. Home
  2. THG vs ALKS Comparison

THG vs ALKS Comparison

Compare THG & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Insurance Group Inc

THG

Hanover Insurance Group Inc

N/A

Current Price

$217.29

Market Cap

7.9B

Sector

Finance

ML Signal

N/A

Logo Alkermes plc

ALKS

Alkermes plc

N/A

Current Price

$40.84

Market Cap

8.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
THG
ALKS
Founded
1852
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
8.7B
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
THG
ALKS
Price
$217.29
$40.84
Analyst Decision
Hold
Buy
Analyst Count
8
19
Target Price
★ $237.75
$56.56
AVG Volume (30 Days)
223.7K
★ 1.7M
Earning Date
10-28-2026
10-27-2026
Dividend Yield
★ 1.77%
N/A
EPS Growth
★ 55.21
N/A
EPS
★ 10.58
N/A
Revenue
★ $6,594,400,000.00
$1,475,899,000.00
Revenue This Year
$2.03
$23.57
Revenue Next Year
$4.15
$6.48
P/E Ratio
$20.74
★ N/A
Revenue Growth
★ 5.72
N/A
52 Week Low
$166.54
$27.00
52 Week High
$236.07
$55.67

Technical Indicators

Market Signals
Indicator
THG
ALKS
Relative Strength Index (RSI) 36.35 31.74
Support Level $203.36 $36.25
Resistance Level $233.50 $51.25
Average True Range (ATR) 3.98 1.42
MACD -1.32 -0.27
Stochastic Oscillator 6.59 15.22

Price Performance

Historical Comparison
THG
ALKS

About THG Hanover Insurance Group Inc

The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business through Hanover Insurance, Citizens and other THG subsidiaries. The company conducts business operations through four operating segments: Core Commercial, Specialty, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: